Business
Wugen rebrands as Allotera, raises USD 150m for off-the-shelf CAR-T push
St. Louis-based Allotera Therapeutics, Inc. (formerly Wugen, Inc.) has closed a USD 35 million financing round comprising equity and venture debt, bringing...
Chemomab, Scipher merge in USD 150 million deal to advance AI-guided RA therapy
Israel-based Chemomab Therapeutics (Nasdaq: CMMB) and Burlington, Massachusetts-based Scipher Medicine Corporation have entered into a definitive merger...
Sino Bio expands GSK partnership into respiratory, securing China rights to USD 4.5b inhaler franchise
GSK is extending its Sino Bio GSK collaboration into respiratory medicine, handing China commercialization rights for two of its highest-revenue inhaled...
AstraZeneca secures ex-China rights to Sino Bio's TQC3721 in USD 2.1b respiratory deal
AstraZeneca has secured ex-China rights to TQC3721, an inhaled dual PDE3/4 inhibitor for COPD, in a deal worth USD 200 million upfront and up to USD 2.1...
Helix secures AstraZeneca partnership to power drug discovery with US genomic data
AstraZeneca has signed a multi-year agreement with San Mateo-based Helix to access its GenoSphere clinico-genomic cohort platform for drug discovery and...
Boehringer Ingelheim acquires viral vector platform from Prime Vector Technologies for cancer vaccines
Boehringer Ingelheim has entered a license agreement with Germany-based Prime Vector Technologies GmbH (PVT) to acquire exclusive rights to its Orf virus...
Semnur secures USD 100m from Kazakhstan investor to advance non-opioid pain candidate
Palo Alto-based Semnur Pharmaceuticals, Inc. (OTC: SMNR), a majority-owned subsidiary of Scilex Holding Company (Nasdaq: SCLX), announced the signing of a...
MeiraGTx secures USD 400m from Oberland Capital to fund gene therapy commercialization
UK-based MeiraGTx Holdings plc (Nasdaq: MGTX) announced a strategic investment of up to USD 400 million from Oberland Capital Management LLC, structured to...
Kalohexis files confidential IPO as oral non-GLP-1 obesity biotech enters public markets
Northbrook, Illinois-based Kalohexis, Inc. — a clinical-stage biotechnology company targeting the melanocortin receptor system for obesity and cancer...
Abivax secures USD 920m to fund US launch of inflammatory bowel disease candidate
France-based Abivax SA (Euronext Paris / Nasdaq: ABVX) announced the closing of a USD 920 million (EUR 807 million) Abivax public offering of American...
MGI Tech's ProtoPilot closes the gap between AI reasoning and wet-lab execution
MGI Tech's subsidiary Genoria AI, in partnership with the Shanghai Artificial Intelligence Laboratory, launched ProtoPilot and BioLab Bench on July 5 — a...
Aureka open-sources biomolecular foundation model for AI drug discovery
Laguna Hills, California-based Aureka has released OpenDDE, an open-source, all-atom biomolecular foundation model designed to serve as a structural...
Beckman Coulter's CE-marked p-Tau217 blood test enables scalable Alzheimer's screening in routine labs
Beckman Coulter Diagnostics has received CE Mark under IVDR for its Access p-Tau217 blood test and simultaneously unveiled a companion research assay, the...
Cyllene Therapeutics secures EUR 33m Series C to advance HSV-based genetic medicine platform
France-based Cyllene Therapeutics, formerly known as EG 427, has closed a EUR 33 million Series C financing round to advance clinical development of EG110A,...
Vertex bets USD 10b on endocrinology diversification with Crinetics acquisition
Vertex Pharmaceuticals has agreed to acquire San Diego-based Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) for USD 85.00 per share in cash, representing a...
The AllSci Brief
Systematic R&D and deal news. Daily.